ZMAX

Adverse Events

Drug Profile

Learn More

Reference

About Results

Comments

Zmax Adverse Events Reported to the FDA Over Time

How are Zmax adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Zmax, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Zmax is flagged as the suspect drug causing the adverse event.

Most Common Zmax Adverse Events Reported to the FDA

What are the most common Zmax adverse events reported to the FDA?

Diarrhoea	61 (8.54%)
Vomiting	29 (4.06%)
Abdominal Pain Upper	24 (3.36%)
Nausea	22 (3.08%)
Pain	18 (2.52%)
Dyspnoea	16 (2.24%)
Drug Ineffective	14 (1.96%)
Malaise	14 (1.96%)
Rash	14 (1.96%)
Urticaria	14 (1.96%)
Hypersensitivity	13 (1.82%)
	Show More
Abdominal Pain	12 (1.68%)
Chills	10 (1.4%)
Headache	10 (1.4%)
Dizziness	9 (1.26%)
Loss Of Consciousness	9 (1.26%)
Pyrexia	8 (1.12%)
Asthenia	7 (.98%)
Dehydration	7 (.98%)
Feeling Abnormal	7 (.98%)
Pruritus	7 (.98%)
Weight Decreased	7 (.98%)
Convulsion	6 (.84%)
Cough	6 (.84%)
Nervousness	6 (.84%)
Cerebrovascular Accident	5 (.7%)
Clostridial Infection	5 (.7%)
Colitis	5 (.7%)
Drug Interaction	5 (.7%)
Insomnia	5 (.7%)
Speech Disorder	5 (.7%)
Syncope	5 (.7%)
Tinnitus	5 (.7%)
Upper Respiratory Tract Infection	5 (.7%)
Arthralgia	4 (.56%)
Blood Glucose Increased	4 (.56%)
Hypotension	4 (.56%)
Abdominal Discomfort	3 (.42%)
Abdominal Distension	3 (.42%)
Ageusia	3 (.42%)
Atrial Fibrillation	3 (.42%)
Burning Sensation	3 (.42%)
Cold Sweat	3 (.42%)
Coma	3 (.42%)
Delirium	3 (.42%)
Dry Skin	3 (.42%)
Eyelid Oedema	3 (.42%)
Faeces Discoloured	3 (.42%)
Feeling Hot	3 (.42%)
Flatulence	3 (.42%)
Gastritis	3 (.42%)
Heart Rate Increased	3 (.42%)
Muscular Weakness	3 (.42%)
Rectal Haemorrhage	3 (.42%)
Swelling Face	3 (.42%)
Swollen Tongue	3 (.42%)
Tachycardia	3 (.42%)
Tongue Paralysis	3 (.42%)
Treatment Noncompliance	3 (.42%)
Unevaluable Event	3 (.42%)
Anaphylactic Reaction	2 (.28%)
Anosmia	2 (.28%)
Arrhythmia	2 (.28%)
Bedridden	2 (.28%)
Blood Glucose Decreased	2 (.28%)
Blood Triglycerides Increased	2 (.28%)
Chest Discomfort	2 (.28%)
Chest Pain	2 (.28%)
Clostridium Difficile Colitis	2 (.28%)
Contusion	2 (.28%)
Crying	2 (.28%)
Deafness Unilateral	2 (.28%)
Diarrhoea Haemorrhagic	2 (.28%)
Discomfort	2 (.28%)
Disease Recurrence	2 (.28%)
Drug Effect Decreased	2 (.28%)
Dysarthria	2 (.28%)
Dysgeusia	2 (.28%)
Dyskinesia	2 (.28%)
Fatigue	2 (.28%)
Fungal Infection	2 (.28%)
Gastrointestinal Haemorrhage	2 (.28%)
Haemorrhage	2 (.28%)
Head Injury	2 (.28%)
Hyperhidrosis	2 (.28%)
Influenza Like Illness	2 (.28%)
Lacrimation Increased	2 (.28%)
Large Intestine Perforation	2 (.28%)
Laryngeal Erythema	2 (.28%)
Lung Neoplasm	2 (.28%)
Mental Impairment	2 (.28%)
Movement Disorder	2 (.28%)
Multiple Sclerosis	2 (.28%)
Muscle Spasms	2 (.28%)
Myalgia	2 (.28%)
Nephrolithiasis	2 (.28%)
Pain In Extremity	2 (.28%)
Palpitations	2 (.28%)
Paraesthesia	2 (.28%)
Rash Generalised	2 (.28%)
Respiratory Tract Infection	2 (.28%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Zmax, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Zmax is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Zmax

What are the most common Zmax adverse events reported to the FDA?

Gastrointestinal Signs	104 (14.57%)
Gastrointestinal Motility And Defec...	63 (8.82%)
Neurological	50 (7%)
Respiratory	39 (5.46%)
Epidermal And Dermal Conditions	37 (5.18%)
Therapeutic And Nontherapeutic Effe...	21 (2.94%)
Allergic Conditions	20 (2.8%)
Infections - Pathogen Unspecified	18 (2.52%)
Angiedema And Urticaria	14 (1.96%)
Headaches	11 (1.54%)
Bacterial Infectious	10 (1.4%)
	Show More
Gastrointestinal Inflammatory Condi...	9 (1.26%)
Anxiety Disorders	8 (1.12%)
Body Temperature Conditions	8 (1.12%)
Cardiac Arrhythmias	8 (1.12%)
Electrolyte And Fluid Balance Condi...	8 (1.12%)
Physical Examination Topics	8 (1.12%)
Gastrointestinal Hemorrhages	7 (.98%)
Lifestyle Issues	7 (.98%)
Medication Errors	7 (.98%)
Movement Disorders	7 (.98%)
Muscle	7 (.98%)
Seizures	7 (.98%)
Sleep Disorders	7 (.98%)
Tongue Conditions	7 (.98%)
Central Nervous System Vascular	6 (.84%)
Injuries	6 (.84%)
Inner Ear And Viiith Cranial Nerve	6 (.84%)
Metabolic, Nutritional And Blood Ga...	6 (.84%)
Upper Respiratory Tract Disorders	6 (.84%)
Cardiac And Vascular Investigations	5 (.7%)
Cranial Nerve Disorders	5 (.7%)
Decreased And Nonspecific Blood Pre...	5 (.7%)
Skin Appendage Conditions	5 (.7%)
Eye	4 (.56%)
Joint	4 (.56%)
Renal Disorders	4 (.56%)
Deliria	3 (.42%)
Embolism And Thrombosis	3 (.42%)
Gastrointestinal Ulceration And Per...	3 (.42%)
Hearing	3 (.42%)
Hepatic And Hepatobiliary	3 (.42%)
Mental Impairment	3 (.42%)
Musculoskeletal And Connective Tiss...	3 (.42%)
Ocular Infections, Irritations And ...	3 (.42%)
Vision	3 (.42%)
Appetite And General Nutritional	2 (.28%)
Bronchial Disorders	2 (.28%)
Cardiac Disorder Signs	2 (.28%)
Demyelinating	2 (.28%)
Fungal Infectious	2 (.28%)
Gastrointestinal Conditions	2 (.28%)
Hematology Investigations	2 (.28%)
Lipid Analyses	2 (.28%)
Oral Soft Tissue Conditions	2 (.28%)
Respiratory And Mediastinal Neoplas...	2 (.28%)
Sleep Disturbances	2 (.28%)
Urinary Tract Signs	2 (.28%)
Urolithiases	2 (.28%)
Vascular Hemorrhagic	2 (.28%)
Viral Infectious	2 (.28%)
Aural	1 (.14%)
Chemical Injury And Poisoning	1 (.14%)
Chlamydial Infectious	1 (.14%)
Exocrine Pancreas Conditions	1 (.14%)
Fatal Outcomes	1 (.14%)
Hematological	1 (.14%)
Legal Issues	1 (.14%)
Neuromuscular	1 (.14%)
Ocular Neuromuscular	1 (.14%)
Pigmentation	1 (.14%)
Platelet	1 (.14%)
Psychiatric And Behavioural Symptom...	1 (.14%)
Pulmonary Vascular	1 (.14%)
Renal And Urinary Tract Investigati...	1 (.14%)
Respiratory And Pulmonary Investiga...	1 (.14%)
Salivary Gland Conditions	1 (.14%)
Skin And Subcutaneous Tissue	1 (.14%)
Spleen, Lymphatic And Reticulendoth...	1 (.14%)
Testicular And Epididymal	1 (.14%)
Tissue	1 (.14%)
Vulvovaginal Disorders	1 (.14%)
Water, Electrolyte And Mineral	1 (.14%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Zmax, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Zmax is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Zmax According to Those Reporting Adverse Events

Why are people taking Zmax, according to those reporting adverse events to the FDA?

Ill-defined Disorder	42
Sinusitis	33
Bronchitis	18
Pneumonia	15
Upper Respiratory Tract Infection	12
Cough	7
	Show More
Pharyngolaryngeal Pain	6
Chlamydial Infection	4
Oropharyngeal Pain	4
Respiratory Tract Infection	3
Sinus Disorder	3
Nasopharyngitis	3
Pharyngitis	3
Tracheobronchitis	3
Sinusitis Bacterial	3
Ear Pain	3
Influenza	2
Lower Respiratory Tract Infection	2
Lung Infection	2
Respiratory Tract Congestion	2
Bronchitis Acute	2
Pharyngitis Streptococcal	2
Malaise	2
Increased Upper Airway Secretion	2
Pyrexia	2
Osteomyelitis	1
Influenza Like Illness	1
Tonsillitis	1
Dyspnoea	1
Condition Aggravated	1
Headache	1
Gonorrhoea	1
Cystitis	1
Ear Infection	1
Tonsillitis Streptococcal	1
Infection	1
Respiratory Disorder	1
Lymphadenopathy	1
Bacterial Infection	1
Viral Infection	1
Bronchitis Chronic	1
Hypersensitivity	1
Cellulitis	1
Gastric Infection	1

Drug Labels

Label	Labeler	Effective
Zmax	Rebel Distributors Corp	26-JAN-11
Zmax	Pfizer Laboratories Div Pfizer Inc	20-APR-12

Zmax Case Reports

What Zmax safety concerns are being reported by doctors and researchers in the medical literature?

About Results

This report contains aggregated drug side effects and adverse events for Zmax. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Zmax.